Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination
Studies on Vaccines & Effectiveness
Scientists Develop Game-Changing Needle-Free COVID-19 Intranasal Vaccine
New vector vaccine against COVID-19 provides long-term protection
Project NextGen
Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters
University of Houston Researchers Create New Treatment and Vaccine for Flu and Various Coronaviruses
An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models
Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adults in England
Review estimates 69% 3-dose vaccine efficacy against long COVID | CIDRAP
Evaluation of Waning of SARS-CoV-2 Vaccine–Induced Immunity
Effectiveness of Bivalent Boosters against Severe Omicron Infection | NEJM
Impact Of Covid-19 Vaccination On The Risk Of Developing Long-Covid And On Existing Long-Covid Symptoms
Protection by a Fourth Dose of BNT162b2 against Omicron in Israel | NEJM
Coronavirus: Covid News: Israeli Study Says Second Booster Protects Against Omicron Infection but Wanes Fast (Published 2022)
Covid-19: Vaccination Reduces Severity and Duration of Long Covid
Vaccination, Paxlovid decrease risk of long Covid, studies show | CNN
The Risks Of Pots After Covid-19 Vaccination And Sars-Cov-2 Infection: It’s Worth A Shot
The bivalent vaccine booster outperforms
COVID-19 Symptoms 6 Months After Onset and the Role of Vaccination for SARS-CoV-2 Infection
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster